Navigation Links
PAREXEL Completes 200 Patient Studies In Its Early Phase Units Over Three Years
Date:11/17/2010

velopment and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 10,170  employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events, including, without limitation, statements regarding expected financial results, future growth and customer demand.
For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements.  Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "will," "would," "could," "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and ret
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Team completes world-first ocean observatory
2. University of Hawaii completes 3-year investigation of military munitions sea disposal site
3. Kornberg Associates
4. Architects Completes UC Riverside Stem Cell Core Facility Project
5. KINAXO Completes Financing Round to Enhance Biomarker Development
6. Pacific Biometrics Completes $4 Million Debt Financing
7. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
8. Lockheed Martin Team Completes Key Design Milestone on Federal Bureau of Investigations Next Generation Identification Program
9. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
10. DOE Joint Genome Institute completes soybean genome
11. Arsenic early in treatment improves survival for leukemia patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... University of Texas at Arlington research team says recently ... in their lab could open doors for homeland security ... published in the Oct. 1 issue of Optics ... his co-authors describe a new method to fabricate transparent ... oxygen until a transparent ceramic is formed. A ...
(Date:9/29/2014)... Washington State University have concluded that nondigestible compounds ... may help prevent disorders associated with obesity. The ... these compounds in apple cultivars grown in the ... the journal Food Chemistry ., "We know ... of these nondigestible compounds but there are differences ...
(Date:9/29/2014)... found compounds that boost liver detoxification enzymes nearly fivefold, ... crushed seeds left after oil extraction from an oilseed ... in Camelina sativa seed, also known as ... that work together synergistically far better than they do ... because its bioactive ingredients increase the liver,s ability to ...
Breaking Biology News(10 mins):UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3An apple a day could keep obesity away 2New way to detox? 'Gold of Pleasure' oilseed boosts liver detoxification enzymes 2
... German Center for Neurodegenerative Diseases (DZNE) and the University ... "NLRP3 inflammasome" is composed of several proteins and plays ... a fire alarm sensor that triggers a chain reaction ... and substances that foster inflammation are released. This process ...
... 19, 2012) -- A new report in the journal ... vast, understudied swath of the animal kingdom that includes as ... genomes of a leech, an ocean-dwelling worm and a kind ... University, the University of California-Berkeley and the Department of Energy,s ...
... that badgers which strayed away from the family burrow in favour ... The 12-month study of 40 wild badgers was funded ... could have implications for the management of bovine TB in parts ... be a key factor in how the disease is spread among ...
Cached Biology News:Alzheimer's disease: Cutting off immune response promises new approach to therapy 2Genomic frontier: The unexplored animal kingdom 2Genomic frontier: The unexplored animal kingdom 3Badger sleeping habits could help target TB control 2
(Date:9/30/2014)... Md., Sept. 30, 2014 BioHealth Innovation, ... commercializing market-relevant biohealth innovations and increasing access to early-stage ... today that venture capitalist, Tania Fernandez , Ph.D., ... Dr. Fernandez will be a member of the management ... provide up to $50 million in seed and early-stage ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The custom ... ISPE Boston Product Show 2014. The Boston Area Chapter ... the 23rd annual, day-long event for Wed., Oct. 1 ... promises to be the largest in ISPE Boston’s long ... upward of 3,000 attendees expected. , HOLLOWAY AMERICA ...
(Date:9/30/2014)... 30, 2014 On September 11, Pharma IQ ... in anticipation of a session that he will lead on ... scheduled for February 17-18, 2015 in London. In the ... asked Dr. Sherley to respond to several questions on the ... to evaluating stem cell toxicity, and future trends in the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... IACRN), a non-profit organization based in Pittsburgh, ... Excellence and Safety (ACRES), a Massachusetts non-profit ... strategic alliance agreement, setting the stage for multiple ... enhance clinical research quality and safety through specialized ...
Breaking Biology Technology:Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3
... $235 Million, SOUTH SAN FRANCISCO, Calif., June 27 ... the company and,GlaxoSmithKline, Inc. (NYSE: GSK ) will ... 27, 2008, as scheduled. Under the,terms of the collaboration, ... of the,compounds in the collaboration for further development and,commercialization. ...
... world will present the latest breakthroughs in electro-optics, lasers ... Conference on Lasers and Electro-Optics/Quantum Electronics and Laser Science ... McEnery Convention Center in San Jose, Calif. , ... lasers and electro-optics community. It will be held in ...
... could be reduced by application of a simple polymer, ... injected into the blood stream as reported in ... , Andrew Koob and Richard Borgens from Purdue University, ... was effective in limiting damage if administered within four ...
Cached Biology Technology:Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration 2Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration 3Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration 4Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration 5Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 2Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 3Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 4Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 5Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 6Detecting dangerous chemicals with lasers, exploring the brain's circuitry with light and more 7
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... a simple and convenient method for the rapid, ... been optimized for use with S. cerevisiae and ... fungus species that is susceptible to yeast lytic ... spheroplasts of yeast cells that are ideal for ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Biology Products: